{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T04:31:41Z","timestamp":1784867501332,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijcha.2025.101809","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T10:06:39Z","timestamp":1758708399000},"page":"101809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Care pathway in patients after myocardial infarction in Denmark \u2212 healthcare and drug utilization"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4948-1581","authenticated-orcid":false,"given":"Marius M\u00f8lsted","family":"Flege","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Kleinschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristoffer Jarlov","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik Kj\u00e6rulf","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten Krogh","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte Ottar","family":"Merland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcha.2025.101809_b0005","unstructured":"bhf-cvd-statistics-global-factsheet.pdf [Internet]. [cited 2024 Aug 30]. Available from: https:\/\/www.bhf.org.uk\/-\/media\/files\/for-professionals\/research\/heart-statistics\/bhf-cvd-statistics-global-factsheet.pdf?rev=e61c05db17e9439a8c2e4720f6ca0a19&hash=6350DE1B2A19D939431D876311077C7B."},{"key":"10.1016\/j.ijcha.2025.101809_b0010","unstructured":"Global health estimates: Leading causes of death [Internet]. [cited 2024 Sep 12]. Available from: https:\/\/www.who.int\/data\/gho\/data\/themes\/mortality-and-global-health-estimates\/ghe-leading-causes-of-death."},{"key":"10.1016\/j.ijcha.2025.101809_b0015","unstructured":"HjerteTal [Internet]. [cited 2024 Sep 17]. Available from: https:\/\/hjerteforeningen.shinyapps.io\/HjerteTal\/?_inputs_&agCVD=%22national%22&bar=%22cvd%22&oCVD=%22d1%22&varCVD=%22v1%22&year=%222022%22."},{"issue":"12","key":"10.1016\/j.ijcha.2025.101809_b0020","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1161\/CIRCRESAHA.114.302721","article-title":"Mechanisms of plaque formation and rupture","volume":"114","author":"Bentzon","year":"2014","journal-title":"Circ. Res."},{"issue":"21","key":"10.1016\/j.ijcha.2025.101809_b0025","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1056\/NEJMoa1600176","article-title":"Cholesterol lowering in intermediate-risk persons without cardiovascular disease","volume":"374","author":"Yusuf","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.ijcha.2025.101809_b0030","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/jama.2016.13985","article-title":"Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis","volume":"316","author":"Silverman","year":"2016","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ijcha.2025.101809_b0035","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)","volume":"41","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.ijcha.2025.101809_b0040","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1185\/030079908X261096","article-title":"One-year costs of ischemic heart disease among patients with acute coronary syndromes: findings from a multi-employer claims database*","volume":"24","author":"Menzin","year":"2008","journal-title":"Curr. Med. Res. Opin."},{"issue":"34","key":"10.1016\/j.ijcha.2025.101809_b0045","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"issue":"34","key":"10.1016\/j.ijcha.2025.101809_b0050","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcha.2025.101809_b0055","unstructured":"2019 Hjerteforloebsprogram.pdf [Internet]. [cited 2024 Sep 20]. Available from: https:\/\/www.regionh.dk\/Sundhedsaftale\/Vaerktoejskasse\/Documents\/2019%20Hjerteforloebsprogram.pdf."},{"key":"10.1016\/j.ijcha.2025.101809_b0060","unstructured":"Danish Medicines Agency [Internet]. [cited 2025 Jul 16]. Reimbursement thresholds. Available from: https:\/\/laegemiddelstyrelsen.dk\/en\/reimbursement\/reimbursement-thresholds\/."},{"key":"10.1016\/j.ijcha.2025.101809_b0065","series-title":"The Danish National Hospital Register. A Valuable Source of Data for Modern Health Sciences","author":"Andersen","year":"1999"},{"issue":"7 Suppl","key":"10.1016\/j.ijcha.2025.101809_b0070","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1403494810394717","article-title":"The Danish national prescription registry","volume":"39","author":"Kildemoes","year":"2011","journal-title":"Scand. J. Public Health"},{"issue":"8","key":"10.1016\/j.ijcha.2025.101809_b0075","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish civil registration system as a tool in epidemiology","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur. J. Epidemiol."},{"issue":"7 Suppl","key":"10.1016\/j.ijcha.2025.101809_b0080","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1403494811405098","article-title":"Danish registers on personal income and transfer payments","volume":"39","author":"Baadsgaard","year":"2011","journal-title":"Scand. J. Public Health"},{"key":"10.1016\/j.ijcha.2025.101809_b0085","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2147\/CLEP.S245060","article-title":"Existing data sources in clinical epidemiology: laboratory information system databases in Denmark","volume":"12","author":"Arendt","year":"2020","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.ijcha.2025.101809_b0090","unstructured":"National health registers \u2013 Sundhedsdatastyrelsen [Internet]. [cited 2024 Sep 2]. Available from: https:\/\/sundhedsdatastyrelsen.dk\/da\/english\/health_data_and_registers\/national_health_registers."},{"key":"10.1016\/j.ijcha.2025.101809_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinepi.2017.08.005","article-title":"The new measuring multimorbidity index predicted mortality better than Charlson and Elixhauser indices among the general population","author":"Stanley","year":"2017","journal-title":"J. Clin. Epidemiol."},{"issue":"1","key":"10.1016\/j.ijcha.2025.101809_b0100","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s12872-020-01616-9","article-title":"Lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment after acute coronary syndrome: a Danish population-based cohort study","volume":"20","author":"Kristensen","year":"2020","journal-title":"BMC Cardiovasc. Disord."},{"issue":"17","key":"10.1016\/j.ijcha.2025.101809_b0105","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/eurheartj\/ehw046","article-title":"Percent reduction in LDL cholesterol following high-intensity statin therapy: potential implications for guidelines and for the prescription of emerging lipid-lowering agents","volume":"37","author":"Ridker","year":"2016","journal-title":"Eur. Heart J."},{"issue":"21","key":"10.1016\/j.ijcha.2025.101809_b0110","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1056\/NEJMsa020080","article-title":"Specialty of ambulatory care physicians and mortality among elderly patients after myocardial infarction","volume":"347","author":"Ayanian","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"251","key":"10.1016\/j.ijcha.2025.101809_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2017.10.048","article-title":"Physician specialty and long-term survival after myocardial infarction \u2013 a study including all German statutory health insured patients","volume":"15","author":"Radzimanowski","year":"2018","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcha.2025.101809_b0120","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.healthpol.2018.02.002","article-title":"No-shows in appointment scheduling \u2013 a systematic literature review","volume":"122","author":"Dantas","year":"2018","journal-title":"Health Policy"},{"issue":"2","key":"10.1016\/j.ijcha.2025.101809_b0125","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1365-2125.2005.02408.x","article-title":"Statin use after acute myocardial infarction: a nationwide study in Denmark","volume":"60","author":"Rasmussen","year":"2005","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijcha.2025.101809_b0130","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.atherosclerosis.2019.03.014","article-title":"Management of dyslipidaemia in patients with coronary heart disease: results from the ESC-EORP EUROASPIRE V survey in 27 countries","volume":"285","author":"De Backer","year":"2019","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.ijcha.2025.101809_b0135","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jacl.2012.03.003","article-title":"Understanding Statin Use in America and Gaps in Patient Education (USAGE): an internet-based survey of 10,138 current and former statin users","volume":"6","author":"Cohen","year":"2012","journal-title":"J. Clin. Lipidol."},{"issue":"6","key":"10.1016\/j.ijcha.2025.101809_b0140","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10557-005-5686-z","article-title":"Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients\u2014the PRIMO study","volume":"19","author":"Bruckert","year":"2005","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"11","key":"10.1016\/j.ijcha.2025.101809_b0145","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/eurheartj\/ehv641","article-title":"Negative statin-related news stories decrease statin persistence and increase myocardial infarction and cardiovascular mortality: a nationwide prospective cohort study","volume":"37","author":"Nielsen","year":"2016","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.ijcha.2025.101809_b0150","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3390\/diseases11040168","article-title":"Comparative efficacy and safety of statin monotherapy and statin plus ezetimibe combination in a real-world setting","volume":"11","author":"Ezhov","year":"2023","journal-title":"Diseases"},{"key":"10.1016\/j.ijcha.2025.101809_b0155","unstructured":"nhs.uk [Internet]. 2017 [cited 2024 Oct 9]. Statins \u2013 Considerations. Available from: https:\/\/www.nhs.uk\/conditions\/statins\/considerations\/."},{"key":"10.1016\/j.ijcha.2025.101809_b0160","unstructured":"Seponerings\u00adlisten 2024 [Internet]. [cited 2024 Oct 11]. Available from: http:\/\/www.sst.dk\/da\/Fagperson\/Ansvarlig-medicinering\/Rationel-farmakoterapi\/Vaerktoejer-til-medicingennemgang\/Seponeringslisten."},{"issue":"4 Suppl 1","key":"10.1016\/j.ijcha.2025.101809_b0165","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1097\/MLR.0000000000001812","article-title":"Impact of COVID-19 on trends in outpatient clinic utilization","volume":"61","author":"McCracken","year":"2023","journal-title":"Med. Care"}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235290672500212X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235290672500212X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T17:08:00Z","timestamp":1773162480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235290672500212X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":33,"alternative-id":["S235290672500212X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2025.101809","relation":{},"ISSN":["2352-9067"],"issn-type":[{"value":"2352-9067","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Care pathway in patients after myocardial infarction in Denmark \u2212 healthcare and drug utilization","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2025.101809","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101809"}}